$0.6965
-0.0035-0.50%
At close: Jul 10, 5:00 PM EST
$0.7150
0.01852.66%
After Hours: Jul 9, 7:18 PM EST
PharmaCyte Biotech Inc Stock Guidance
PMCBNASDAQ
PharmaCyte Biotech (PMCB) last issued guidance on July 11, 2022 for fiscal year 2022. The company guided earnings per share in the range of $-0.27 - $-0.27, compared to a consensus EPS estimate of $-0.24.
Latest Guidance Date
Jul 11, 2022
Guidance Period
Full Year 2022
EPS Guidance Range
$-0.27 - $-0.27
PharmaCyte Biotech Guidance History
Review all historical guidance issued by PharmaCyte Biotech, including EPS and revenue forecasts across quarterly and annual periods.
Loading calendar...
FAQ
What is the most recent guidance for PharmaCyte Biotech (PMCB)?
The most recent guidance for PharmaCyte Biotech (PMCB) was reported on July 11, 2022 for the fiscal year 2022. The company provided earnings per share guidance in the range of $-0.27 to $-0.27, compared to the estimated EPS of $-0.24.
What EPS range did PharmaCyte Biotech (PMCB) guide for?
PharmaCyte Biotech (PMCB) guided EPS in the range of $-0.27 to $-0.27 for the fiscal year 2022. The consensus analyst EPS estimate is $-0.24.
When did PharmaCyte Biotech (PMCB) last issue guidance?
PharmaCyte Biotech (PMCB) last issued guidance on July 11, 2022 for the fiscal year 2022.
